BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23628324)

  • 41. The synergistic effect between the Mediterranean diet and GSTP1 or NAT2 SNPs decreases breast cancer risk in Greek-Cypriot women.
    Kakkoura MG; Loizidou MA; Demetriou CA; Loucaides G; Daniel M; Kyriacou K; Hadjisavvas A
    Eur J Nutr; 2017 Mar; 56(2):545-555. PubMed ID: 26572891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [POLYMORPHISM OF GLUTHATIONE-S-TRANSFERASE P1 IN CHILDREN WITH REFLUX-ESOPHAGITIS].
    Zagorskiy SE; Melnov SB; Sinevich EA
    Lik Sprava; 2015; (1-2):134-5. PubMed ID: 26118046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.
    Krajinovic M; Ghadirian P; Richer C; Sinnett H; Gandini S; Perret C; Lacroix A; Labuda D; Sinnett D
    Int J Cancer; 2001 Apr; 92(2):220-5. PubMed ID: 11291049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
    Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
    Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Detoxication gene polymorphism and susceptibility to sporadic motor neuron disease in Russian population].
    Skvortsova VI; Slominskiĭ PA; Shadrina MI; Levitskiĭ GN; Levitskaia NI; Alekhin AV; Zherebtsova AL; Serdiuk AV; Limborskaia SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):4-13. PubMed ID: 16459354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.
    Glesse N; Rohr P; Monticielo OA; Rech TF; Brenol JC; Xavier RM; Kvitko K; Chies JA
    Mol Biol Rep; 2014 Sep; 41(9):6167-79. PubMed ID: 24981927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study.
    Rodrigo L; Alvarez V; Rodriguez M; Pérez R; Alvarez R; Coto E
    Scand J Gastroenterol; 1999 Mar; 34(3):303-7. PubMed ID: 10232877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.
    Martínez-Ramírez OC; Pérez-Morales R; Castro C; Flores-Díaz A; Soto-Cruz KE; Astorga-Ramos A; Gonsebatt ME; Casas L; Valdés-Flores M; Rubio J
    Breast; 2013 Jun; 22(3):335-43. PubMed ID: 23000097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.
    González MV; Alvarez V; Pello MF; Menéndez MJ; Suárez C; Coto E
    J Clin Pathol; 1998 Apr; 51(4):294-8. PubMed ID: 9659241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
    Rana SV; Sharma SK; Ola RP; Kamboj JK; Malik A; Morya RK; Sinha SK
    J Clin Pharm Ther; 2014 Feb; 39(1):91-6. PubMed ID: 24188272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
    Khedhaier A; Hassen E; Bouaouina N; Gabbouj S; Ahmed SB; Chouchane L
    BMC Cancer; 2008 Apr; 8():109. PubMed ID: 18423013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India.
    Mittal RD; Srivastava DS; A M; B M
    Asian Pac J Cancer Prev; 2005; 6(1):6-9. PubMed ID: 15780023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigation.
    Farker K; Schotte U; Scheele J; Hoffmann A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):120-4. PubMed ID: 11911601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
    Feng FM; Guo M; Chen Y; Li SM; Zhang P; Sun SF; Zhang GS
    Genet Mol Res; 2014 Nov; 13(4):9463-71. PubMed ID: 25501156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes.
    Buch SC; Nazar-Stewart V; Weissfeld JL; Romkes M
    Head Neck; 2008 Sep; 30(9):1139-47. PubMed ID: 18642288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus.
    Lee JM; Lee YC; Yang SY; Shi WL; Lee CJ; Luh SP; Chen CJ; Hsieh CY; Wu MT
    Int J Cancer; 2000 Sep; 89(5):458-64. PubMed ID: 11008209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.